Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|August 15, 2012
Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremiaJonathan Z Li, Sebastien Gallien, Tri D Do, et al.Plos One|July 19, 2012
Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatmentLuca Musante, Mayank Saraswat, Elodie Duriez, et al.Proteomics. Clinical Applications|February 7, 2015
Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC-MS in PRM modeAntoine Lesur, Lina Ancheva, Yeoun Jin Kim, et al.Cancer Research|January 29, 2021
High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human TumorsLauren E Stopfer, Cameron T Flower, Aaron S Gajadhar, et al.Proteomics|February 18, 2011
Toward a standardized urine proteome analysis methodologyMagali Court, Nathalie Selevsek, Mariette Matondo, et al.Molecular & Cellular Proteomics : MCP|July 24, 2007
High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycositesJianru Stahl-Zeng, Vinzenz Lange, Reto Ossola, et al.Genome Biology|February 14, 2007
Interrupted coding sequences in Mycobacterium smegmatis: authentic mutations or sequencing errors?Caroline Deshayes, Emmanuel Perrodou, Sebastien Gallien, et al.JAMA Oncology|January 7, 2022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer AgentsCharlotte Fenioux, Luis Teixeira, Slim Fourati, et al.Journal of the American Society for Mass Spectrometry|March 5, 2004
Quantitation of phosphopeptides using affinity chromatography and stable isotope labelingTao He, Kim Alving, Brian Feild, et al.Nature Methods|December 8, 2009
High-throughput generation of selected reaction-monitoring assays for proteins and proteomesPaola Picotti, Oliver Rinner, Robert Stallmach, et al.Pageof 9